INTRODUCTION.
According to the World Health Organization (WHO), cancer is the leading cause of death worldwide. In 2012 there were 36.2 million people living with cancer and 8.2 million people died from this disease 1,2 . The WHO is now conducting the GLO-BOCAN project, which provides data on mortality and prevalence of cancer (including oral cancer) in different geographical areas. GLOBOCAN reported a mortality of 1.8% globally for oral cancer 3 .
One way to study the survival rate of oral cancer is by anatomical location. This includes the lining mucosa of the lips, the inside of the cheek, palate, anterior two-thirds of the tongue, floor of the mouth and alveolar ridge, maxillary and palatine bones, major and mi-nor salivary glands 4 . Of these, the most affected area is the vermilion of the lower lip, followed by the side edge of the tongue, floor of the mouth, the inside of the cheek and the mucosa of the alveolar ridge 5, 6 .
The objective of this narrative review is to describe the survival and mortality rates of oral cancer by anatomical location at national and global scale.
Lip cancer Most data reported in the literature is related to survival of oral squamous cell carcinoma and melanoma on the lower lip. Neville et al. 6 and Salihu et al. 7 place particular emphasis on the survival rate according to the TNM stage of the patient. It is noteworthy that the higher the TNM stage, the lower the survival rate. The data reported by these authors at 5 and 10 years respectively are shown in Table 1 . Zini et al. 5 think that between 6.6% to 26.5% of lip cancer cases at the time of diagnosis are associated with metastasis in cervical lymph nodes, specifically submental and submandibular lymph nodes. Its survival rate ranges from 25% to 50% at 5 years.
Other malignant lesions such as melanoma can also be found at this location. According Jing et al. 8 , melanoma is more common in the lower lip and has a survival rate of 56% at 5 years. In addition, it has a 46% chance of regional metastases in lymph nodes. Still, labial melanoma has the lowest rate of regional/ distance metastases and better prognosis than other melanomas of the oral mucosa.
In Chile, Riera et al. 9 reported that mortality from lip cancer accounted for 9% of all deaths from oral cancer between 1950 and 2002. Ramirez et al. 10 indicated that for the decade 2002-2012 lip cancer accounted for only 4%. Colil et al. 11 in the Valparaiso region reported a mortality of 4.05% for the period 2001-2010, with a male/female ratio of 2.7: 1.
Tongue cancer Records on survival rate for tongue cancer refer to squamous cell carcinoma (SCC). Authors like Neville et al. 6 , Rodrigues et al. 12 , and Azimi et al. 13 indicate that survival beyond five years will depend on the location of lingual tumor and TNM stage. At diagnosis, almost 50% of all carcinomas of the tongue have already metastasized 14 . Therefore, Rodrigues et al. 12 suggest that nodal involvement plays an important role in the prognosis, since its presence is associated with decreased survival.
Capote-Moreno et al. 14 reported an incidence of 31.4% of contralateral metastasis when the tongue base is affected, and 7.2% in the movable tongue. According to the American Cancer Society (ACS) 4 , the survival rate at 5 years with local metastasis is 78%, 63% with regional, and 36% with distance metastasis.
Neville et al. 6 and Zini et al. 5 indicated that when the tumor is located at the base of the tongue survival at 5 years is 42.6%. In other areas of the tongue the percentages range from 40% to 49.9%. Table 2 shows the correlation of different clinical characteristics with the survival rate at 5 years according to Azimi et al. 13 and Rodrigues et al. 12 In Chile, according to Riera et al. 9 , tongue cancer accounted for 39% of deaths from oral cancer. According to Ramirez et al. 10 of the total number of cases, 16.9% were men and 19.7%, women. Colil et al. 11 reported that tongue cancer mortality was 12.6%, with a male/female ratio of 3.6:1.
Cancer of the floor of the mouth Most of the information found in the literature refers to SCC of the floor of the mouth. As the carcinoma of the tongue, the floor of the mouth carcinoma is one of the more aggressive and more likely to spread Survival and mortality from oral cancer by anatomical location. Narrative review. at distant locations 15 . Capote-Moreno et al. 14 reported that the incidence of contralateral local nodal metastasis is 11%. According to ACS 4 , the relative survival rate at 5 years with local metastasis is 75%, 38% with regional, and 20% with distance metastasis. Marsiglia et al. 16 found that when treated by radiation therapy, the survival rate of patients with cancer on the floor of mouth at TNM stages I and II at 2 years was 89% and 76% at 5 years. Pimienta Amaral et al. 17 reported an overall survival rate of 68.5% at 5 years in patients with SCC at TNM stages I and II of tongue and floor of mouth cancer. When considering all TNM stages, Rikimaru et al. 18 reported an overall survival rate of 88% at 3 years, a 100% for stages I and II, and 67% for stages III and IV.
In Chile, according to Riera et al. 9 , the floor of the mouth cancer accounted for 18% of deaths from oral cancer. According to Ramirez et al. 10 of the total number of patients affected by this neoplasia 10.6% were men and 6.8%, women. Colil et al. 11 reported a mortality rate of 3.37%, with a male/female ratio of 4:1.
Palate cancer For this location the survival data available are related to SCC, adenocarcinoma and melanoma. In the hard palate Zini et al. 5 reported a survival rate of 50-59% at 5 years for SCC. Yang et al. 19 found a survival rate ranging from 57% to 67% between 3 and 5 years. Li et al. 20 found the following survival rate at 5 years, considering the regional nodal involvement: N0 47.36%, N1 27.48%, N2 15.55%, and N3 0%.
Zini et al. 5 reported that a in the case of a SCC in the soft palate, survival varies between 60% and 69.9% at 5 years. However, this figure decreased with nodal involvement, N1 27.48%, N2 15.55%, Table 2 . Tongue cancer and survival rate at 5 years according to demographic and clinical parameters.
Rodrigues et al. 12 Azimi et al. 13 Parameters Characteristics Survival at 5 years Survival at 5 years and N3 0%. With respect to the adenoid cystic carcinoma, Li et al. 21 reported that with surgical therapy rates were 75%, 37.5%, and 25% at 5, 10 and 15 years, respectively. With surgery and radiotherapy rates were 70.6%, 35 .3%, and 20.8% at 5, 10 and 15 years, respectively. Regarding oral melanoma survival rates according to location and histological type of the affected mucosa were considered. For the keratinized area, a survival rate ranging between 5% and 20% at 5 years was found 19, 22 .
In Chile, Ramirez et al. 10 reported that the mortality rate for palate cancer is 3.9% for men and 4.2% for women of all deaths from oral cancer. According to Colil et al. 11 palate cancer accounted for 3.37%, with a male/ female ratio of 4:1.
Cancer of the alveolar ridge Survival data described corresponds to carcinomas, as it is the most common neoplasia in this location, specifically in the posterior mandibular area. There are no data about mortality or survival with respect to this anatomical location in Chile.
Nakasato et al. 23 reported a survival rate of 70% at 5 years for SCC. However, this rate decreases to 30.8% in the presence of metastases in the regional lymph area 24 . In the maxillary alveolar ridge and hard palate, Rikamuru et al. 25 found a survival rate of 27% at 3 years, and 60% for the mandibular ridge area.
Cancer of the mandible Survival data described corresponds to osteosarcoma (most common malignancy of the maxillary area, particularly relevant is its location in the jaw) 26 and lymphomas (the second most common malignancy in this area) 27 .
With respect to osteosarcomas, Lee et al. 26 reported that the overall survival rate at 5 and 10 years is 53% and 35%, respectively. The rate of disease-specific survival at 5 and 10 years is 62% and 54%, respectively.
Steve et al. 28 reported that the survival rate at 5 years is 50%. Similar data was found by Paparella et al. 29 , as they obtained a survival rate of 68% at 5 years.
Lymphomas in the jaws have a survival rate of 55% at 5 years. This percentage drops to 30% if the lymphoma is located at the maxillary sinus 27, 30 .
In Chile, Colil et al. 11 reported that cancer of the jawbone accounted for 8.78% of the total deaths from oral cancer. The male/female ratio was 1:1.1.
Salivary Gland Cancer
Malignant neoplasms of the salivary glands are more than 0.5% of all cancers and account for approximately 3-5% of all cancers of the head and neck. Malignancy varies according to location: 20% to 25% for tumors of the parotid, 35% to 40% for submandibular tumors, 50% for palate tumors, and more than 90% for sublingual gland tumors 31 .
The National Cancer Institute (NCI) 31 reports that the most common malignancy of the major and minor salivary glands is the mucoepidermoid carcinoma, accounting for about 10% of all salivary gland neoplasms.
With respect to the major salivary glands, Maza-Solano et al. 32 found that survival at 5 years for malignant parotid gland tumors was 60%. Speight et al. 33 in a study of adenocarcinomas of low, medium and high grade malignancy in the parotid gland, found survival rates of 91%, 41% and 50%, respectively.
Malignant tumors of the submandibular gland are rare and most are treated with surgery. Pohad et al. 34 found a median overall survival of 59 months for malignant tumors of the submandibular gland, the survival rate at 5 years was 50% and 28% at 10 years. In sublingual gland tumors, Zdanowski et al. 35 reported an overall survival rate of 78.7% at 5 years and a rate of disease-free survival of 87.5%.
Luksic et al. 36 revealed a survival rate of 62%, 53%
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and 27% at 5, 10 and 15 years, respectively, in minor salivary glands with adenoid cystic carcinoma and perineural invasion. In neoplasms that had no perineural invasion, an overall survival rate of 90% was observed. ACS 37 classifies the survival rate of these lesions depending on the clinical stage of the tumor (Table 3) .
Overall, approximately 72% of people diagnosed with major salivary gland cancer are still alive at least 5 years after diagnosis. However, there are other factors that should be taken into account because they may also affect the survival and prognosis of the disease, such as a person's medical history, age, type and grade of the tumor and biological condition of the patient 37 . Guzzo et al. 38 linked the histological type of these tumors with survival rates (Table 4 ).
In Chile, according to Riera et al. 9 , mortality from cancer of major salivary glands accounted for 30% of total deaths from oral cancer, affecting a 65% of men and 35% of women, with a male/female ratio of 1.4:1.
They found that mortality from salivary gland cancer increased steadily with age, and the highest number of deaths was in those patients over 75 years (35.4%), affecting a 50.3% and a 49.7% of men and women, respectively. Ramirez et al. 10 reported that the number of deaths from cancer of salivary glands was 12.8% for men and 20.2% for women. Colil et al. 11 reported a mortality of 14.86% from cancer of major salivary glands of the total deaths from oral cancer. Men were affected in a 11.76% and women in a 19.04%.
DISCUSSION.
Most of the available literature covers specifically the clinical and pathological characteristics of squamous cell carcinoma, possibly because of its high frequency.
There is little information about other primary cancers located in the mouth, such as sarcomas, lymphomas, melanomas and even metastasis.
Available information on oral cancer in different anatomical locations only provides survival rates. No Table 3 . Five-year survival of salivary gland cancer by TNM stage 37 . survival data were found regarding the Chilean population. There are no indicators of mortality available for the different anatomical areas either. In Chile, data linking the death rate from oral cancer in each anatomical location with the total cases of oral cancer is the only information available. Given that the information used in this study comes from databases provided by the WHO and national cancer registries and hospitals is not surprising to observe different values of survival rate for each anatomical location. Three reports on oral cancer mortality in Chile were found. Rates and figures reported varied among the different studies according to the source of information and period studied. Riera et al. 9 Given the above, results presented here are not comparable, but they may help identify the most vulnerable areas of the mouth and improve prognosis. Neoplasms affecting the tongue, floor of mouth, palate and alveolar ridge have the worst prognosis. Conversely, the lower lip has the best prognosis. However, this may vary according to the size of the tumor, presence of nodal metastasis, distant metastasis and the general characteristics of the patient.
Survival rates presented in this review have the aim to encourage oral cancer prevention campaigns. We need to emphasize the importance of self-examination of the oral cavity to identify suspicious lesions and improve the management of oral cancer in the various health institutions, as oral cancers diagnosed early and treated promptly have better prognosis and a higher chance of cure. Resumen: El cáncer oral es un problema a nivel mundial, alcanzando el 6 to lugar en frecuencia entre todos los tipos de cáncer, pudiendo afectar a distintas zonas de la cavidad oral. Las tasas de supervivencia están influenciadas por diversos factores, tales como: tipo histológico, tamaño del tumor, presencia de metástasis regional y/o distancia y el estado biológico del paciente. Según la OMS, la tasa de supervivencia del cáncer oral a los 5 años es de 53 a 56%. El objetivo de esta revisión es describir la tasa de supervivencia y mortalidad del cáncer oral según zona anatómica afectada a nivel mundial y nacional. A nivel mundial, la tasa de supervivencia para las localizaciones de labio, lengua, piso de boca, paladar, huesos maxilares, reborde alveolar y glándulas salivares variaron entre un 0% a 100%. Sin embargo, en Chile no se ha reportado la tasa de supervivencia para las diferentes localizaciones anatómicas. En el mundo y en nuestro país, no se encontró información relacionada con tasa de mortalidad para las distintas zonas anatómicas. Se considera que las neoplasias orales que afectan la lengua, el piso de boca, el paladar y el reborde alveolar son las de peor pronóstico, y que por el contrario, las que afectan al labio inferior son los de mejor pronóstico.
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